Our Mission
Onco Briefs makes cutting-edge cancer research accessible and entertaining. We translate peer-reviewed studies from journals like Cell Reports, Nature, eLife, and The Lancet into clear, engaging summaries that anyone can understand.
What We Cover
Our coverage spans the full breadth of cancer research and oncology:
- Immunotherapy - CAR-T cells, checkpoint inhibitors, and immune-based cancer treatments
- Tumor Biology - How cancers grow, spread, and evade the immune system
- Clinical Trials - Promising new therapies moving from bench to bedside
- Cancer Genomics - Mutations, biomarkers, and the genetics of cancer
- Precision Medicine - Targeted therapies tailored to individual tumors
- Drug Development - New compounds, combination therapies, and therapeutic breakthroughs
- Cancer Prevention - Screening advances, risk factors, and early detection
Editorial Standards
Every post on Onco Briefs is based on published, peer-reviewed research. We include DOI links and PubMed IDs (PMIDs) for every study we cover, so you can always read the original paper yourself. Our images are clearly labeled as illustrative and do not depict actual experimental data.
Stay Connected
Subscribe to our weekly newsletter for the best new cancer research, explained without the jargon. You can also browse our full archive of articles.